Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;50(1):15-21.
doi: 10.3347/kjp.2012.50.1.15. Epub 2012 Mar 6.

A recombinant Plasmodium vivax apical membrane antigen-1 to detect human infection in Iran

Afsaneh Motevalli Haghi  1 , Mohammad Reza Khoramizade, Mehdi Nateghpour, Mehdi Mohebali, Gholam Hossein Edrissian, Mohammad Reza Eshraghian, Zargham Sepehrizadeh
Affiliations

A recombinant Plasmodium vivax apical membrane antigen-1 to detect human infection in Iran

Afsaneh Motevalli Haghi et al. Korean J Parasitol. 2012 Mar.

Abstract

In Iran, Plasmodium vivax is responsible for more than 80% of the infected cases of malaria per year. Control interventions for vivax malaria in humans rely mainly on developed diagnostic methods. Recombinant P. vivax apical membrane antigen-1 (rPvAMA-1) has been reported to achieve designing rapid, sensitive, and specific molecular diagnosis. This study aimed to perform isolation and expression of a rPvAMA-1, derived from Iranian patients residing in an endemic area. Then, the diagnostic efficiency of the characterized Iranian PvAMA-1 was assessed using an indirect ELISA method. For this purpose, a partial region of AMA-1 gene was amplified, cloned, and expressed in pET32a plasmid. The recombinant His-tagged protein was purified and used to coat the ELISA plate. Antibody detection was assessed by indirect ELISA using rPvAMA-1. The validity of the ELISA method for detection of anti-P. vivax antibodies in the field was compared to light microscopy on 84 confirmed P. vivax patients and compared to 84 non-P. vivax infected individuals. The ELISA cut-off value was calculated as the mean+2SD of OD values of the people living in malaria endemic areas from a south part of Iran. We found a cut-off point of OD=0.311 that showed the best correlation between the sera confirmed with P. vivax infection and healthy control sera. A sensitivity of 81.0% and specificity of 84.5% were found at this cut off titer. A good degree of statistical agreement was found between ELISA using rPvAMA-1 and light microscopy (0.827) by Kappa analysis.

Keywords: AMA-1; ELISA; Iran; Plasmodium vivax; microscopy; recombinant antigen.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
SDS-PAGE analysis for rPvAMA-1 production. Lane 1: E. coli BL21(DE 3) bacterial lysate containing pET 32 a plasmid (negative control). Lane 2: E. coli BL21(DE 3) bacterial lysate containing pET 32 a-AMA-1 recombinant plasmid. Lane 3: Protein size marker.
Fig. 2
Fig. 2
SDS-PAGE analysis of rPvAMA-1 expression. PSM: protein size marker (kDa). PvAMA-1: His tagged recombinant antigen purified by Ni-NTA affinity column after IPTG induction.
See this image and copyright information in PMC

References

    1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214–217. - PMC - PubMed
    1. Greenwood B, Mutabingwa T. Malaria in 2002. Nature. 2002;415:670–672. - PubMed
    1. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: Past, present, and future. Lancet Infect Dis. 2004;4:327–336. - PMC - PubMed
    1. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64(1-2 suppl):97–106. - PubMed
    1. Edrissian GH. Malaria in Iran: past and present situation. Iranian J Parasitol. 2006;1:1–14.

Publication types

MeSH terms